- Home
- / Cimeio
Cimeio
Total Funding
$50 M
Cimeio Summary
Company Summary
- Overview
- Cimeio Therapeutics is a company developing proprietary cell-shielding technology and immunotherapies to treat diseases. It offers Shielded-Cell and Immunotherapy Pairs, a suite of treatments for genetic diseases, hematologic malignancies, and severe autoimmune disorders.
- Type
- Private
- Status
- Active
- Founded
- 2020
- HQ
- Basel, CH | view all locations
- Website
- https://www.cimeio.com/
- Cybersecurity rating
Table of Contents
LocationsView all
1 location detected
Basel, BS HQ
Switzerland
Aeschenvorstadt 36
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026